Migdal Insurance & Financial Holdings’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-12
Closed -$1K 713
2020
Q2
$1K Buy
12
+5
+71% +$241 ﹤0.01% 674
2020
Q1
$0 Sell
7
-197
-97% -$9.73K ﹤0.01% 711
2019
Q4
$12K Sell
204
-6,230
-97% -$338K ﹤0.01% 698
2019
Q3
$329K Sell
6,434
-1,055
-14% -$50.2K 0.01% 394
2019
Q2
$317K Buy
7,489
+1,256
+20% +$54.5K 0.01% 373
2019
Q1
$308K Sell
6,233
-4,228
-40% -$191K 0.01% 356
2018
Q4
$453K Buy
+10,461
New +$522K 0.01% 275

Other funds holding GMED

Migdal Insurance & Financial Holdings's GMED Position: Q3 2020 in Review

Migdal Insurance & Financial Holdings sold out of Globus Medical (GMED) in Q3 2020, closing a stake of 12 shares — an estimated $1K sold.

Migdal Insurance & Financial Holdings first reported a position in GMED in Q4 2018 and held it in 7 quarters. The position peaked at $453K in Q4 2018. 344 funds tracked by Wall St. Rank hold GMED as of Q3 2020.

  • Migdal Insurance & Financial Holdings reported no remaining Globus Medical position as of Q3 2020 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 12 Globus Medical shares in Q3 2020, an estimated $1K.
  • Migdal Insurance & Financial Holdings first reported a position in Globus Medical in Q4 2018 and held it in 7 quarters.
  • Migdal Insurance & Financial Holdings's Globus Medical position peaked at $453K in Q4 2018.
  • 344 funds tracked by Wall St. Rank held Globus Medical as of Q3 2020.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q3 2020, filed 5 Nov 2020.